Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear
- 1Institute of Special Environmental Medicine, and Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China
- 2Department of Radiology, The Second People’s Hospital of Nantong and Affiliated Rehabilitation Hospital of Nantong University, Nantong, Jiangsu, China
Abstract
Previous studies have suggested that aldosterone is potentially involved in the development of motion sickness and that atrial natriuretic peptide (ANP) may inhibit it. Therefore, the present study was conducted to investigate the inhibitory effects of ANP on aldosterone activity in motion sickness and on aldosterone-induced changes in endolymph volume in the inner ear. We found that rotatory stimulation induced an elevation in plasma aldosterone levels, intraperitoneal aldosterone injection caused motion sickness-like responses in both guinea pigs and mice, and ANP inhibited these responses. Moreover, aldosterone injection induced an increase in inner ear endolymph volume in guinea pigs, whereas ANP alleviated this endolymph expansion. In addition, mineralocorticoid receptor (MR) expression was increased in the inner ear tissues after rotatory stimulation and aldosterone injection, and in cultured vestibular epithelial cells after aldosterone treatment, whereas ANP reduced MR expression. In cultured vestibular epithelial cells, ANP reduced the aldosterone-induced nuclear distribution of MR, as well as the expression of ENaC and Na+-K+-ATPase and the membrane distribution of Na+-K+-ATPase. Furthermore, ANP inhibited the aldosterone-induced increase in the intracellular K+ concentration in cells incubated with a simulated endolymph fluid, and the increase in intracellular Na+ concentration in cells incubated with an extracellular solution. In conclusion, the present results suggest that ANP may play an anti-motion sickness role by reducing the plasma aldosterone levels and inhibiting aldosterone-induced endolymph expansion by downregulating downstream target protein expression and activities, thereby altering the resultant ion concentrations in the inner ear epithelial cells.
Related
- Sacubitrilat exerts potent antiarrhythmic effects through activation of natriuretic peptide receptor-C
- Serial N-Terminal pro B-Type Natriuretic Peptide in the Community ― Dynamic Risk Signal or Incremental Predictor? ―
- Natriuretic Peptide Receptor-C (NPR3) in Pulmonary Hypertension Associated with Chronic Lung Disease: A PRISMA-ScR Scoping Review of Diagnostic, Prognostic, Mechanistic, and Therapeutic Evidence
- Coexisting adrenal hemangioma and aldosterone-producing micronodule presented as adrenal incidentaloma
- The Aldosterone–Immune Axis in Primary Aldosteronism: Linking Adrenal Pathogenesis to Systemic Inflammation and Target-Organ Damage
BibTeX
@article{lu2026atrial,
title = {{Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear}},
author = {Qian-Cheng Lu and Wei Ji and Xia Li and Jian-Gang Ge and Li-Hua Xu and Zheng-Lin Jiang},
journal = {PLOS One},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0359426},
url = {https://doi.org/10.1371/journal.pone.0359426},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear
AU - Qian-Cheng Lu
AU - Wei Ji
AU - Xia Li
AU - Jian-Gang Ge
AU - Li-Hua Xu
AU - Zheng-Lin Jiang
PY - 2026
DA - 2026/09/25
JO - PLOS One
DO - 10.1371/journal.pone.0359426
UR - https://doi.org/10.1371/journal.pone.0359426
AB - Previous studies have suggested that aldosterone is potentially involved in the development of motion sickness and that atrial natriuretic peptide (ANP) may inhibit it. Therefore, the present study was conducted to investigate the inhibitory effects of ANP on aldosterone activity in motion sickness and on aldosterone-induced changes in endolymph volume in the inner ear. We found that rotatory stimulation induced an elevation in plasma aldosterone levels, intraperitoneal aldosterone injection caused motion sickness-like responses in both guinea pigs and mice, and ANP inhibited these responses. Moreover, aldosterone injection induced an increase in inner ear endolymph volume in guinea pigs, whereas ANP alleviated this endolymph expansion. In addition, mineralocorticoid receptor (MR) expression was increased in the inner ear tissues after rotatory stimulation and aldosterone injection, and in cultured vestibular epithelial cells after aldosterone treatment, whereas ANP reduced MR expression. In cultured vestibular epithelial cells, ANP reduced the aldosterone-induced nuclear distribution of MR, as well as the expression of ENaC and Na+-K+-ATPase and the membrane distribution of Na+-K+-ATPase. Furthermore, ANP inhibited the aldosterone-induced increase in the intracellular K+ concentration in cells incubated with a simulated endolymph fluid, and the increase in intracellular Na+ concentration in cells incubated with an extracellular solution. In conclusion, the present results suggest that ANP may play an anti-motion sickness role by reducing the plasma aldosterone levels and inhibiting aldosterone-induced endolymph expansion by downregulating downstream target protein expression and activities, thereby altering the resultant ion concentrations in the inner ear epithelial cells.
SN - 1932-6203
ER -